Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Patient treatment preferences and the 5-HT1B/1D agonists.

R E Ryan1

  • 1Ryan Headache Center, Department of Otolaryngology, St. Louis University School of Medicine, St Louis, MO 63017, USA. drrerjr@aol.com

Archives of Internal Medicine
|December 26, 2001
PubMed
Summary

Migraine patients prefer fast, complete relief and minimal side effects from medications. Specific triptans offer varying success in meeting these individual migraine treatment preferences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The histologic effect of repeated application of certain nose drops to the nasal mucous membrane of rabbits.

The Annals of otology, rhinology, and laryngology·2010
Same author

Vasomotor rhinitis medicamentosa viewed histologically.

Proceedings of the staff meetings. Mayo Clinic·2010
Same author

Measurements of the phase shift on reflection for low-order infrared Fabry-Perot interferometer dielectric stack mirrors.

Applied optics·2008
Same author

Audio-visual presentation of information for informed consent for participation in clinical trials.

The Cochrane database of systematic reviews·2008
Same author

Lanepitant, an NK-1 antagonist, in migraine prevention.

Cephalalgia : an international journal of headache·2001
Same author

Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

British journal of pharmacology·2001

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Migraineurs have distinct preferences for migraine therapy.
  • Key attributes sought include rapid, complete pain relief, return to normal functioning, symptom relief, reduced recurrence, and minimal adverse effects.

Purpose of the Study:

  • To highlight the importance of patient preferences in migraine treatment selection.
  • To discuss the role of 5-HT(1B/1D) agonists (triptans) in meeting these preferences.

Main Methods:

  • Review of patient surveys on migraine therapy preferences.
  • Analysis of the attributes of the triptan class of migraine medications.

Main Results:

  • Triptans generally provide effective pain and symptom relief, allowing a return to normal activities.

Related Experiment Videos

  • Individual triptan formulations demonstrate variability in satisfying patient preferences for migraine relief.

    • Conclusions:

    • Physicians should consider individual patient preferences when prescribing migraine medications.
    • Understanding the differences among triptans is crucial for optimizing migraine treatment outcomes.